BioCentury
ARTICLE | Clinical News

Cornerstone Pharmaceuticals preclinical data

October 10, 2011 7:00 AM UTC

In mouse xenograft models of melanoma and non-small cell lung cancer (NSCLC), EmPAC produced greater tumor growth inhibition than that of Taxol paclitaxel. In rabbits, a single IV injection of 22.5 m...